Association between serum uric acid levels and cardiovascular disease in middle-aged and elderly Chinese individuals

BMC Cardiovascular Disorders

Volumn 14, Issue , 2014, Pages

  Qin, Li ^a   Yang, Zhen ^a   Gu, Hongxia ^a   Lu, Shuai ^a   Shi, Qun ^a   Xing, Yin ^a   Li, Xiaoyong ^a   Li, Rui ^b   Ning, Guang ^c   Su, Qing ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b Shanghai Municipal Center for Disease Control and Prevention   (China)

^c SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

Cardiovascular disease; Coronary heart disease; Metabolic syndrome; Stroke; Uric acid

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHINESE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERURICEMIA; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC EQUIVALENT; METABOLIC SYNDROME X; MIDDLE AGED; POPULATION DISTRIBUTION; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; QUESTIONNAIRE; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; WAIST CIRCUMFERENCE;

AGE FACTORS; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CHINA; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERURICEMIA; LINEAR MODELS; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PREVALENCE; RISK FACTORS; UP-REGULATION; URIC ACID;

EID: 84898598646     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-14-26     Document Type: Article

References (41)

1. Wu Z, Yao C, Zhao D, Wu G, Wang W, Liu J, Zeng Z, Wu Y. Sino-MONICA project: a collaborative study on trends and determinants in cardiovascular diseases in China, part I: morbidity and mortality monitoring. Circulation 2001, 103:462-468. 10.1161/01.CIR.103.3.462, 11157701.
2. Yang Z, Wang X, Wen J, Ye Z, Li Q, He M, Lu B, Ling C, Wu S, Hu R. Prevalence of non-alcoholic fatty liver disease and its relation to hypoadiponectinaemia in the middle-aged and elderly Chinese population. Arch Med Sci 2011, 665-672.
3. He Y, Jiang B, Wang J, Feng K, Chang Q, Fan L, Li X, Hu FB. Prevalence of the metabolic syndrome and its relation to cardiovascular disease in an elderly Chinese population. J Am Coll Cardiol 2006, 47:1588-1594. 10.1016/j.jacc.2005.11.074, 16630995.
4. Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP. Prospective analysis of the insulin-resistance syndrome (Syndrome X). Diabetes 1992, 41:715-722. 10.2337/diab.41.6.715, 1587398.
5. Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissén M, Taskinen MR, Groop L. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001, 24:683-689. 10.2337/diacare.24.4.683, 11315831.
6. Trevisan M, Liu J, Bahsas FB, Menotti A. Syndrome X and mortality:a population-based study. Risk Factor and Life Expectancy Research Group. Am J Epidemiol 1998, 148:958-966. 10.1093/oxfordjournals.aje.a009572, 9829867.
7. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002, 288:2709-2716. 10.1001/jama.288.21.2709, 12460094.
8. So A, Thorens B. Uric acid transport and disease. J Clin Invest 2010, 120:1791-1799. 10.1172/JCI42344, 2877959, 20516647.
9. Neogi T, Ellison RC, Hunt S, Terkeltaub R, Felson DT, Zhang Y. Serum uric acid is associated with carotid plaques: the National Heart, Lung, and Blood Institute Family Heart Study. J Rheumatol 2009, 36:378-384. 2731484, 19012359.
10. Bos MJ, Koudstaal PJ, Hofman A, Witteman JC, Breteler MM. Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study. Stroke 2006, 37:1503-1507. 10.1161/01.STR.0000221716.55088.d4, 16675740.
11. Franse LV, Pahor M, Di Bari M, Shorr RI, Wan JY, Somes GW, Applegate WB. Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program (SHEP). J Hypertens 2000, 18:1149-1154. 10.1097/00004872-200018080-00021, 10954008.
12. Juraschek SP, Tunstall-Pedoe H, Woodward M. Serum uric acid and the risk of mortality during 23 years follow-up in the Scottish Heart Health Extended Cohort Study. Atherosclerosis 2014, 233:623-629. 10.1016/j.atherosclerosis.2014.01.026, 24534458.
13. Ito H, Abe M, Mifune M, Oshikiri K, Antoku S, Takeuchi Y, Togane M. Hyperuricemia is independently associated with coronary heart disease and renal dysfunction in patients with type 2 diabetes mellitus. PLoS One 2011, 6:e27817. 10.1371/journal.pone.0027817, 3220675, 22125626.
14. Freedman DS, Williamson DF, Gunter EW, Byers T. Relation of serum uric acid to mortality and ischemic heart disease. The NHANES I Epidemiologic Follow-up Study. Am J Epidemiol 1995, 141:637-644.
15. Krishnan E, Baker JF, Furst DE, Schumacher HR. Gout and the risk of acute myocardial infarction. Arthritis Rheum 2006, 54:2688-2696. 10.1002/art.22014, 16871533.
16. Verdecchia P, Schillaci G, Reboldi G, Santeusanio F, Porcellati C, Brunetti P. Relation between serum uric acid and risk of cardiovascular disease in essential hypertension. The PIUMA study. Hypertension 2000, 36:1072-1078. 10.1161/01.HYP.36.6.1072, 11116127.
17. Li Q, Yang Z, Lu B, Wen J, Ye Z, Chen L, He M, Tao X, Zhang W, Huang Y, Zhang Z, Qu S, Hu R. Serum uric acid level and its association with metabolic syndrome and carotid atherosclerosis in patients with type 2 diabetes. Cardiovasc Diabetol 2011, 10:72. 10.1186/1475-2840-10-72, 3163178, 21816063.
18. Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA. Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) 2010, 62:170-180. 3156692, 20191515.
19. Culleton BF, Larson MG, Kannel WB, Levy D. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med 1999, 131:7-13. 10.7326/0003-4819-131-1-199907060-00003, 10391820.
20. Brand FN, McGee DL, Kannel WB, Stokes J, Castelli WP. Hyperuricemia as a risk factor of coronary heart disease: The Framingham Study. Am J Epidemiol 1985, 121:11-18.
21. Moriarity JT, Folsom AR, Iribarren C, Nieto FJ, Rosamond WD. Serum uric acid and risk of coronary heart disease: Atherosclerosis Risk in Communities (ARIC) Study. Ann Epidemiol 2000, 10:136-143.
22. Guidelines for data processing and analysis of the International Physical Activity Questionnaire (IPAQ) 2006, Available at: http://www.ipaq.ki.se/.
23. WHO/MONICA-Project Multinational Monitoring of Trends andDeterminants in Cardiovascular Diseases (MONICA Project) and Manual of Operation 1983, Geneva, Switzerland: World Health Organization, Cardiovascular Disease Unit, WHO/MONICA-Project.
24. Liu J, Grundy SM, Wang W, Smith SC, Vega GL, Wu Z, Zeng Z, Wang W, Zhao D. Ethnic-Specific Criteria for the Metabolic Syndrome. Diabetes Care 2006, 29:1414-1416. 10.2337/dc06-0481, 16732037.
25. Takayama S, Kawamoto R, Kusunoki T, Abe M, Onji M. Uric acid is an independent risk factor for carotid atherosclerosis in a Japanese elderly population without metabolic syndrome. Cardiovasc Diabetol 2012, 11:2. 10.1186/1475-2840-11-2, 3293733, 22234039.
26. Perlstein TS, Gumieniak O, Williams GH, Sparrow D, Vokonas PS, Gaziano M, Weiss ST, Litonjua AA. Uric acid and the development of hypertension: the normative aging study. Hypertension 2006, 48:1031-1036. 10.1161/01.HYP.0000248752.08807.4c, 17060508.
27. Shankar A, Klein R, Klein BE, Nieto FJ. The association between serum uric acid level and long-term incidence of hypertension: Population-based cohort study. J Hum Hypertens 2006, 20:937-945. 10.1038/sj.jhh.1002095, 17024135.
28. Masuo K, Kawaguchi H, Mikami H, Ogihara T, Tuck ML. Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension 2003, 42:474-480. 10.1161/01.HYP.0000091371.53502.D3, 12953019.
29. Nakanishi N, Okamoto M, Yoshida H, Matsuo Y, Suzuki K, Tatara K. Serum uric acid and risk for development of hypertension and impaired fasting glucose or Type II diabetes in Japanese male office workers. Eur J Epidemiol 2003, 18:523-530.
30. Dehghan A, Van Hoek M, Sijbrands EJ, Hofman A, Witteman JC. High serum uric acid as a novel risk factor for type 2 diabetes. Diabetes Care 2008, 31:361-362.
31. Rathmann W, Funkhouser E, Dyer AR, Roseman JM. Relations of hyperuricemia with the various components of the insulin resistance syndrome in young black and white adults: the CARDIA study. Coronary Artery Risk Development in Young Adults. Ann Epidemiol 1998, 8:250-261.
32. Khosla UM, Zharikov S, Finch JL, Nakagawa T, Roncal C, Mu W, Krotova K, Block ER, Prabhakar S, Johnson RJ. Hyperuricemia induces endothelial dysfunction. Kidney Int 2005, 67:1739-1742. 10.1111/j.1523-1755.2005.00273.x, 15840020.
33. Iseki K, Ikemiya Y, Inoue T, Iseki C, Kinjo K, Takishita S. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort. Am J Kidney Dis 2004, 44:642-650. 10.1053/j.ajkd.2004.06.006, 15384015.
34. Davies KJ, Sevanian A, Muakkassah-Kelly SF, Hochstein P. Uric acid-iron ion complexes. A new aspect of the antioxidant functions of uric acid. Biochem J 1986, 235:747-754. 1146751, 3753442.
35. Fang J, Alderman MH. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA 2000, 283:2404-2410. 10.1001/jama.283.18.2404, 10815083.
36. Niskanen LK, Laaksonen DE, Nyyssonen K, Alfthan G, Lakka HM, Lakka TA. Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Arch Intern Med 2004, 164:1546-1551. 10.1001/archinte.164.14.1546, 15277287.
37. Chen L, Yang Z, Lu B, Li Q, Ye Z, He M, Huang Y, Wang X, Zhang Z, Wen J, Liu C, Qu S. Hu R:Serum CXC ligand 5 is a new marker of subclinical atherosclerosis in type 2 diabetes. Clin Endocrinol (Oxf) 2011, 75:766-770. 10.1111/j.1365-2265.2011.04119.x, 21609350.
38. Yang Z, Zhang Z, Wen J, Wang X, Lu B, Yang Z, Zhang W, Wang M, Feng X, Ling C, Wu S, Hu R. Elevated serum chemokine CXC ligand 5 levels are associated with hypercholesterolemia but not a worsening of insulin resistance in Chinese people. J Clin Endocrinol Metab 2010, 95:3926-3932. 10.1210/jc.2009-2194, 20501684.
39. Huang Y, Yang Z, Ye Z, Li Q, Wen J, Tao X, Chen L, He M, Wang X, Lu B, Zhang Z, Zhang W, Qu S, Hu R. Lipocalin-2, glucose metabolism and chronic low-grade systemic inflammation in Chinese people. Cardiovasc Diabetol 2012, 11:11. 10.1186/1475-2840-11-11, 3295671, 22292925.
40. Rajendra NS, Ireland S, George J, Belch JJ, Lang CC, Struthers AD. Mechanistic insights into the therapeutic use of high-dose allopurinol in angina pectoris. J Am Coll Cardiol 2011, 58:820-828. 10.1016/j.jacc.2010.12.052, 21835317.
41. Noman A, Ang DS, Ogston S, Lang CC, Struthers AD. Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trial. Lancet 2010, 375:2161-2167. 10.1016/S0140-6736(10)60391-1, 2890860, 20542554.